(Circulation. 1999;99:3322.)
© 1999 American Heart Association, Inc.
Images in Cardiovascular Medicine |
From the Cardiology Division, Rabin Medical Center Beilinson Campus, Tel Aviv University Sackler School of Medicine, Israel, and the Cyclotron Unit Medical Research Council Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Correspondence to Dr Eldad Rechavia, Cardiology Division, Rabin Medical Center Beilinson Campus, Petach Tikva 49100, Israel.
Metabolic aspects, perfusion autoregulation, and
receptor-mediated cardiac responses of the orthotopic cardiac
transplant have gained increasing attention in the past few years. We
recently assessed glucose uptake in vivo in orthotopic heart transplant
recipients.1 Enhanced myocardial uptake as demonstrated by
[18F]2-fluoro-2-deoxyglucose
(18FDG) and PET scanning
was explained by inefficient
metabolic utilization of glucose by the transplanted
myocardium or by the influence of circulating
catecholamines, which may stimulate glucose uptake
independently of cardiac workload. We also studied a 48-year-old male
patient 6 months after heterotopic heart transplantation. Glucose
uptake was assessed by use of 18FDG and PET
imaging, with the basic premise that this parameter gives
direct evidence of glucose metabolic state and myocardial
viability in both cardiac allograft and the native poorly contracting
heart, which was left in situ. Regional 18FDG
uptake (mL · s-1 ·
g-1) was defined as the ratio of the average
18FDG pixel counts in the various tissue regions
of the left ventricle to the integral of the arterial input
function, as previously described.1 Regional
18FDG uptake was on average 285% higher in the
transplanted heart than in the native heart (Figure
). This stems
largely from the difference in myocardial tissue viability, as well as
probably reflecting functional-metabolic coupling of the
transplanted heart as opposed to the native heart.
|
Footnotes
The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.
Circulation encourages readers to submit cardiovascular images to Dr Hugh A. McAllister, Jr, St Luke's Episcopal Hospital and Texas Heart Institute, 6720 Bertner Ave, MC1-267, Houston, TX 77030.
References
1. Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo LI, Jones T, Maseri A, Yacoub MH. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol. 1997;30:533538.[Abstract]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |